38. Xu, MJ., Wu, D*., Barry, F., O’Shea, D., Endogenous Labelling Extracellular Vesicles Derived from Bone Marrow Mesenchymal Stem Cells with a NIR-AZA Fluorophore. ChemRxiv.
37. Cao, N., jiang, Y., Yan, YJ., Wu, D., Chen, ZL., Synthesis and evaluation of new thieno[3,2-b]thiophene-fused BODIPY derivatives as efficient photosensitizers for photodynamic therapy. Journal of Medicinal Chemistry, 2023, under review.
36. Caulfield, C., Wu, D., O’Shea, D, et al. BF2-Azadipyrromethene Fluorophores for Intraoperative Vital Structure Identification. Molecules, 2023, 28(5), 2167.
35. Caulfield, C., O’Shea, D., Wu, D.* Dynamic Bioorthogonal Imaging using a Tetrazine NIR-AZA Fluorogenic Probe, Tetrahedron, 2023, 138, 133387.
34. Wu, D., Durán-Sampedro, G., Fitzgerald, S., Garre, M., O’Shea, D., Double Click Macrocyclization with Sondheimer Diyne of Aza-Dipyrrins for B-Free Bioorthogonal Imaging, Chem Comm. 2023, 59, 1951-1954.
33. Curtin, N.,Garre, M., Wu, D.,O’Shea D. Identifying STEDable BF2-Azadipyrromethene Fluorophores, Molecules, 2023, 28(3), 1415.
32. Caulfield, C., Wu, D., Garre M., O’Shea, D., Substituent Directed Cellular Imaging in the 800-850 nm range with BF2-Azadipyrromethene Fluorophores, RSC Advances 2023,13, 14963-14973.
31. Benowitz, N.L., Havel, C., Jacob, P., O’Shea, D., Wu, D., Fowles, J., Vaping THC‑O Acetate: Potential for Another EVALI Epidemic, Journal of Medical Toxicology 2023, 19, 37-39.
30. Malallah, R., Gallagher, G., Hardy, N., Dalli, J., Wu, D., O’Shea, D., Sheridan, J., Cahill R., Indocyanine green (ICG) fluorescence detection from colon tissue using flexible bundle-fiber optics, Clinical Biophotonics II 2022, 12146, 1214608.
29. Netufo, O., Connor, K., Shiels, LP., Wu, D., O’Shea, D., Miller IS., Byrne AT., Refining Glioblastoma surgery through the use of intra-operative fluorescence imaging agents, Pharmaceuticals 2022, 15(5), 550.
28. Wu, D., Kishimoto, A., O’Shea D., Forecasting vaping health risks through artificial intelligence prediction of flavour pyrolysis reactions, Nature Communication 2022, under review.
27. Wu, D., Aonghusa, PM., O’Shea, DF., Correlation of national and healthcare workers COVID-19 infection data; implications for large-scale viral testing programs, Plos One 2021, 16 (4), e0250699.
26. Curtin, N., Wu, D., R Cahill, A Sarkar, P Mac Aonghusa, S Zhuk, M Barberio, Dual color imaging from a single BF2-Azadipyrromethene fluorophore demonstrated in vivo for lymph node identification. International journal of medical sciences 2021, 18 (7), 1541.
25. Wu, D., O’Shea, D.F. Vaping additive yields an ‘exceptionally toxic’ by-product. Nature 579, 474 (2020) doi: https://doi.org/10.1038/d41586-020-00808-9 (research highlights)
24. Wu, D., O’Shea, D.F. Potential for release of pulmonary toxic ketene from vaping pyrolysis of vitamin E acetate. Proceedings of the National Academy of Sciences of the USA, 2020, 117 (12) 6349.
23. Daly, H.C., Conroy, E., Wu, D., Gallagher, W.M., O’Shea, D.F. An EPR strategy for bio-responsive fluorescence guided surgery with simulation of the benefit for imaging. Theranostics 2020; 10(7):3064.
22. Gao, Y., Zhu, W., Wu, D., Chen, D., Yan, Y., Nguyen T., Phuong A., Wu, X., Chen, Z., Synthesis and evaluation of novel abalone toxin derivatives as potent photosensitizers for photodynamic therapy. European Journal of Medicinal Chemistry, 2020, 187, 111959.
21. Wu, D., Daly, H.C., Grossi, M., Conroy, E., Li, B., Gallagher, W.M., O’Shea, D.F. RGD conjugated cell uptake off to on responsive NIR-AZA fluorophores: applications toward intraoperative fluorescence guided surgery. Chemical Science, 2019, 10, 6944.
20. Wu, D., Durán-Sampedro, G., O’Shea, D.F. Synthesis and properties of water soluble 1,9-dialkyl substituted BF2 azadipyrromethene (NIR-AZA) fluorophores. Frontiers of Chemical Science and Engineering, 2019,1-8.
19. Wu, D., Daly, H.C., Conroy, E., Li, B., Gallagher, W.M., Cahill, R.A., O’Shea, D.F. PEGylated BF2 azadipyrromethene (NIR-AZA) fluorophores for intraoperative imaging. European Journal of Medicinal Chemistry 2019, 161, 343.
18. Henari, F.Z., O’Shea, D., Wu, D., Nonlinear optical measurements of BF2 aza dipyrromethene fluorophores. Chemical Physics Letters: X, 2019, 100020.
17. Wu, D., Cheung, S., Sampedro, G., Chen, Z.-L., Cahill, R.A., O’Shea, D.F. A DIE responsive NIR-fluorescent cell membrane probe. BBA Biomembranes 2018, 1860, 2272.
16. Wu, D., O’Shea, D., Mulligan, N., Loughman,E., Kockhar, HA., Cahill, R., Optical discrimination of primary colorectal cancer using systemic Indocyanine green with near-infrared laparoscopy and microscopy: clinical pilot experience, Irish Journal of medical science 2018,187, S159.
15. Monopoli, M.P., Zendrini, A., Wu, D., Cheung, S., Sampedro, G., Ffrench, B., Nolan, J., Piskareva, O., Stalings, R.L., Ducoli, S., Bergese, P., O’Shea, D.F. Endogenous exosome labelling with an amphiphilic NIR-fluorescent probe. Chemical Communications 2018, 54, 7219.
14. Cheung, S., Wu, D., Daly, H., Busschaert, N.; Morgunova, M., Simpson, J., Scholz, D., Gale, P.A., O’Shea, D.F. Real-time recording of the cellular effects of the anion transporter prodigiosin. Chem 2018, 4, 879.
13. Kitteringham, E., Wu, D., Cheung, S., Twamley, B., O’Shea, D.F., Griffith, D.M. Development of a novel carboplatin like cytoplasmic trackable near infrared fluorophore conjugate via strain-promoted azide alkyne cycloaddition. Journal of Inorganic Biochemistry 2018, 182, 150.
12. Kaltner, H., Manning, J.C., Caballero, G.G., Di Salvo, C., Gabba, A., Romero-Hernandez, L.L., Knospe, C., Wu, D., Daly, H.C., O’Shea, D.F., Gabius, H.J., Murphy, P.V. Revealing bio-medically relevant cell and lectin type-dependent structure-activity profiles for glycoclusters by using tissue sections as an assay platform. RSC Advances 2018, 8, 28716.
11. Wu, D., O’Shea, D.F. Fluorogenic NIR-probes based on 1,2,4,5-tetrazine substituted BF2-azadipyrromethenes. Chemical Communications 2017, 53, 10804.
10. Wu, D., O’Shea, D.F. Comparative triad of routes to an alkyne-BF2 azadipyrromethene near-infrared fluorochrome. Tetrahedron Letters 2017, 58(47), 4468.
9. Daly, H.C., Sampedro, G., Bon, C., Wu, D., Ismail, G., Cahill, R.A., O’Shea, D.F. BF2-azadipyrromethene NIR-emissive fluorophores with research and clinical potential. European Journal of Medicinal Chemistry 2017, 135, 392.
8. Wu, D., Cheung, S., O’Sullivan, C.J., Gao, Y.H., Chen, Z.L., O’Shea, D.F. Strained alkyne substituted near infrared BF2 azadipyrromethene fluorochrome. RSC Advances 2016, 6, 87373.
7. Zhu W., Bao X., Ren H., Da Y., Wu D., Li F., Yan Y., Wang L., Chen Z., N-Phenyl indole derivatives as AT1 antagonists with anti-hypertension activities: Design, synthesis and biological evaluation. European Journal of Medicinal Chemistry 2016, 115, 161.
6. Wu, D., Cheung, S., Devocelle, M., Zhang, L., Chen, Z.L., O’Shea, D.F. Synthesis and assessment of a maleimide functionalized BF2 azadipyrromethene near-infrared fluorochrome. Chemical Communications 2015, 51, 16667.
5. Wu, D., Cheung, S., Daly, R., Burke, H., Scanlan, E.M., O’Shea, D.F. Synthesis and glycoconjugation of an azido BF2 azadipyrromethene near-infrared fluorochrome. European Journal of Organic Chemistry 2014, 6841.
4. Giordani, S., Bartelmess, J., Frasconi, M., Biondi, I., Cheung, S., Grossi, M., Wu, D., Echegoyend, L., O’Shea, D.F. NIR fluorescence 1 labelled carbon nano-onions: Synthesis, analysis and cellular imaging. Journal of Materials Chemistry B 2014, 2, 7459.
3. Zheng, H. L., Zhu, W. B., Wu, D., Da, Y. J., Yan, Y. J., Bian, J., & Chen, Z. L. Synthesis and Biological Evaluation of a New Angiotensin II Receptor Antagonist. Drug Research 2014, 64(12), 656.
2. Zhu W., Da Y., Wu D., Zheng H., Zhu L., Wang L., Yan Y., Chen Z., Design, synthesis and biological evaluation of new 5-nitro benzimidazole derivatives as AT1 antagonists with anti-hypertension activities. Bioorganic & Medicinal Chemistry 2014, 22, 2294.
1. Wu, D., O’Shea, D.F. Synthesis and Properties of BF2-3,3-Dimethyldiaryl azadipyrromethene near-infrared fluorophores. Organic Letters 2013, 15, 3392.